Evidence map›Paper›PMID 32715270›Full record

ArticleJournal of the Endocrine Society2020

Satoshi Yoshiji, Yorihiro Iwasaki, Kanako Iwasaki, Sachiko Honjo, Koichi Hirano, Katsuhiko Ono, Yuto Yamazaki, Hironobu Sasano, Akihiro Hamasaki

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Pathogenic mobile element insertion in theJournal of medical genetics · 2026
    Article
  2. Journal of the Endocrine Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Satoshi YoshijiDepartment of Diabetes and Endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.ORCID 0000-0001-8863-2413
Yorihiro IwasakiDepartment of Diabetes and Endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.ORCID 0000-0001-9787-7922
Kanako IwasakiDepartment of Diabetes and Endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.ORCID 0000-0003-1671-3980
Sachiko HonjoDepartment of Diabetes and Endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
Koichi HiranoDepartment of Laboratory Medicine, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
Katsuhiko OnoDepartment of Anatomic Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Yuto YamazakiDepartment of Anatomic Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Hironobu SasanoDepartment of Anatomic Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.ORCID 0000-0002-6600-8641
Akihiro HamasakiDepartment of Diabetes and Endocrinology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.ORCID 0000-0002-1903-9752
Kitano Hospital · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder caused by mutations of the tumor suppressor gene

Indexed as

Alu/Alu-mediated genomic rearrangementAlu retrotransposonloss of heterozygositymultiple endocrine neoplasia type 1

Identifiers

PMID32715270
PMCPMC7371388
OpenAlexW3021538647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.